Figure 2From: Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic (A) Distribution of mutations along the PKD2 coding sequence. Mutations described in this report have been combined with pathogenic mutations identified from the PKD mutation database. Other = non-sense, frame-shift and insertion/deletion mutations). (B) Percentage of total PKD2 mutations (red); each exon's percentage of the total coding sequence (blue).Back to article page